These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 504071)

  • 41. [Clinical follow-up of a group of hypertensive patients during the year after finishing a therapeutic study with a new hypotensive drug].
    Ocon Pujadas J
    Rev Clin Esp; 1973 Feb; 128(4):331-6. PubMed ID: 4700584
    [No Abstract]   [Full Text] [Related]  

  • 42. Debrisoquin sulfate: a clinical evaluation of a new antihypertensive agent.
    Blechman M; Sokol C; Moser M
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):71-6. PubMed ID: 4975816
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical evaluation of hygroton K (author's transl)].
    Rylski M; Rawczyńska-Englert I; Hoffman M
    Przegl Lek; 1981; 38(10):735-6. PubMed ID: 7036232
    [No Abstract]   [Full Text] [Related]  

  • 44. [On the hypotensive effect of debrisoquin sulfate (Declinax)].
    Honorato F; Ortolá RP
    Rev Med Univ Navarra; 1973 Dec; 17(4):339-44. PubMed ID: 4807215
    [No Abstract]   [Full Text] [Related]  

  • 45. Why hypertensive patients vary in their response to oral debrisoquine.
    Silas JH; Lennard MS; Tucker GT; Smith AJ; Malcolm SL; Marten TR
    Br Med J; 1977 Feb; 1(6058):422-5. PubMed ID: 837136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hypertension treatment: weight reduction training or drugs?].
    Franz IW
    ZFA (Stuttgart); 1983 Sep; 59(27):1477-83. PubMed ID: 6649818
    [No Abstract]   [Full Text] [Related]  

  • 47. [Results of treatment with a new antihypertensive drug. Clinical study in patients with essential and secondary arterial hypertension].
    Spartera C; Faraglia V; Lauri D; Reale R; Matteoni R
    Minerva Med; 1972 Nov; 63(83):4501-9. PubMed ID: 4565311
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical evaluation of metolazone, a long-acting antihypertensive/diuretic.
    Weingarten C
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):737-44. PubMed ID: 827419
    [No Abstract]   [Full Text] [Related]  

  • 49. [The effect of therapeutic diuresis in carbohydrate tolerance in essential hypertension (author's transl)].
    Luque Otero M; Fernández Pinilla C; Bórquez M; Fernández Cruz A; Fernández Cruz A
    Med Clin (Barc); 1981 Jun; 77(1):27-9. PubMed ID: 7019599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Long-term antihypertensive therapy with Etozoline].
    Felix G; Bonn ; Otrzonsek G; Windsheimer F; Schneider B
    Med Welt; 1980 Apr; 31(16):603-7. PubMed ID: 7392925
    [No Abstract]   [Full Text] [Related]  

  • 51. Proceedings: A correlation between the response to debrisoquine and the amount of unchanged drug excreted in the urine.
    Angelo M; Dring LG; Lancaster R; Latham A; Smith RL
    Br J Pharmacol; 1975 Oct; 55(2):264P. PubMed ID: 1201404
    [No Abstract]   [Full Text] [Related]  

  • 52. [New sympathoplegic antihypersensive agent: debrisoquin sulfate].
    Biron P
    Union Med Can; 1973 May; 102(5):1134-5. PubMed ID: 4712043
    [No Abstract]   [Full Text] [Related]  

  • 53. [Action of tienilic acid, a diuretic modifying the tubular system of the excretion of organic acids (author's transl)].
    Bruchez B; Salamin L; Balant L; Fabre J
    Schweiz Rundsch Med Prax; 1978 Feb; 67(6):211-8. PubMed ID: 625477
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cardiovascular response to isometric exercise test during beta blocker and diuretic treatment in essential arterial hypertension].
    Maiorano G; Contursi V; Saracino E; Ricapito M; Di Lecce G
    Clin Ter; 1988 Mar; 124(6):443-50. PubMed ID: 2904846
    [No Abstract]   [Full Text] [Related]  

  • 55. Nitrendipine and mefruside in elderly hypertensives: effects on blood pressure, cardiac output, cerebral blood flow and metabolic parameters.
    Landmark K; Forsman M; Lindberg K; Ryman T; Martmann-Moe K; Haaverstad S; Wiel S
    J Hum Hypertens; 1995 Apr; 9(4):281-5. PubMed ID: 7595911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term follow-up study of hypertensive patients by practicing internists after a controlled drug trial.
    Waeber B; Avigdor L; Brunner HR
    Clin Ther; 1984; 6(4):509-17. PubMed ID: 6432326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Trial of the diuretic agent bumetanid (author's transl)].
    Kym V; Binswanger U
    Schweiz Rundsch Med Prax; 1979 Jan; 68(4):110-6. PubMed ID: 760113
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of hypertension with obsilazin].
    Sirakova V; Penkov N; Kaponov Kh; Dimitrov G
    Vutr Boles; 1986; 25(2):32-6. PubMed ID: 2872755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical testing of a new potassium-saving diuretic for the treatment of hypertension].
    Vetter G
    Munch Med Wochenschr; 1973 Dec; 115(49):2249-50. PubMed ID: 4592408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.